SUZANNE CHESTNUT: Open Payments
NPI 1447905179 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 29 payments from 12 companies in 2025. Trend: 2023 $100 · 2024 $1,263 · 2025 $1,701
Food & beverage: $1,701
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $432 |
| Novo Nordisk Inc | 3 | $255 |
| ABBVIE INC. | 6 | $234 |
| Stryker Corporation | 1 | $161 |
| Amgen Inc. | 5 | $159 |
| Boston Scientific Corporation | 1 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $129 |
| Vanda Pharmaceuticals Inc. | 1 | $93 |
| Exact Sciences Corporation | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: BREZTRI, FLOWTRIEVER, WATCHMAN FLX, UPLIZNA, QULIPTA, TEZSPIRE, Ozempic, Lynkuet.
Industry payments across FL — which companies pay providers there.
